Healthcare
Stocks Ranked by
Market Capitalization
| # | Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|---|
| 1 |
1
Eli Lilly
LLY
$999B
| $999B | $1,120.15 | 0.11% |
|
| 2 |
2
Johnson & Johnson
JNJ
$611B
| $611B | $253.42 | 0.39% |
|
| 3 |
3
AbbVie
ABBV
$431B
| $431B | $243.63 | 0.6% |
|
| 4 |
4
UnitedHealth
UNH
$372B
| $372B | $409.83 | 1.33% |
|
| 5 |
5
Merck
MRK
$319B
| $319B | $129.21 | 1.13% |
|
| 6 |
6
Novartis
NVS
$292B
| $292B | $153.57 | 0.07% |
|
| 7 |
7
AstraZeneca
AZN
$243B
| $243B | $156.75 | 0.77% |
|
| 8 |
8
Thermo Fisher Scientific
TMO
$209B
| $209B | $566.58 | 1.3% |
|
| 9 |
9
Amgen
AMGN
$209B
| $209B | $386.76 | 2.08% |
|
| 10 |
NVO
10
Novo Nordisk
NVO
$195B
| $195B | $44.16 | 6.22% |
|
| 11 |
11
Abbott
ABT
$183B
| $183B | $105.94 | 1.1% |
|
| 12 |
12
Gilead Sciences
GILD
$163B
| $163B | $131.42 | 0.21% |
|
| 13 |
13
Pfizer
PFE
$145B
| $145B | $25.42 | 1.56% |
|
| 14 |
14
Danaher
DHR
$138B
| $138B | $196.93 | 0.29% |
|
| 15 |
15
CVS Health
CVS
$134B
| $134B | $104.67 | 0.66% |
|
| 16 |
16
Bristol-Myers Squibb
BMY
$133B
| $133B | $65.35 | 0.18% |
|
| 17 |
17
Intuitive Surgical
ISRG
$129B
| $129B | $366.17 | 2.46% |
|
| 18 |
18
Stryker
SYK
$128B
| $128B | $334.88 | 1.85% |
|
| 19 |
19
Vertex Pharmaceuticals
VRTX
$122B
| $122B | $479.51 | 1.87% |
|
| 20 |
20
Medtronic
MDT
$110B
| $110B | $86.08 | 0.69% |
|
| 21 |
21
GSK
GSK
$103B
| $103B | $51.50 | 0.02% |
|
| 22 |
22
Sanofi
SNY
$102B
| $102B | $42.73 | 0.51% |
|
| 23 |
23
McKesson
MCK
$97.2B
| $97.2B | $829.90 | 0.33% |
|
| 24 |
24
HCA Healthcare
HCA
$86.2B
| $86.2B | $398.14 | 2.08% |
|
| 25 |
25
Elevance Health
ELV
$82.6B
| $82.6B | $381.04 | 0.45% |
|
Healthcare Stocks at a Glance
Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.
There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.93T.
The largest by market cap are Eli Lilly (LLY) at $999B, Johnson & Johnson (JNJ) at $611B and AbbVie (ABBV) at $431B.
Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.
- Combined market cap: $8.93T across 1,066 stocks.
- Largest constituent: Eli Lilly (LLY), $999B market cap.
- Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.